Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Das Thema chronische Unterbauch- und Viszeralschmerzen wird im Live-Webinar am 7. Mai von 17.30 bis 19 Uhr aus internistischer, gynäkologischer und psychologisch-neurowissenschaftlicher Perspektive beleuchtet. Besprochen werden krankheitsbedingte Ursachen, Mechanismen der kognitiven Schmerzmodulation sowie mögliche Therapieoptionen. Die Fortbildung ist mit 2 CME-Punkten zertifiziert. Melden Sie sich jetzt an!
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 2/2013

01.04.2013 | Minimally Invasive Surgery (V Bird, Section Editor)

Evaluation of Renal Masses with Contrast-Enhanced Ultrasound

verfasst von: S. Houtzager, H. Wijkstra, J. J. M. C. H. de la Rosette, M. P. Laguna

Erschienen in: Current Urology Reports | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The clinical need for characterising small renal masses (SRMs) is increasing due to their rising incidental detection. This increase is especially seen in younger and older generations and concerns mainly SRMs. Diagnostics is mainly made by contrast-enhanced CT or MRI. However, these imaging methods fail to accurately distinguishing benign from malignant SRMs. Other disadvantages of CT or MRI are high costs, the use of ionizing radiation, nephrotoxicity induced by iodine contrast agents or nephrogenic systemic fibrosis (NSF) induced by gadolinium contrast agents. Contrast-enhanced ultrasound (CEUS) is based on ultrasonography and microbubbles to real-time visualize the renal blood flow without the use of nephrotoxic agents or ionizing radiation. This comprehensive review evaluates the capabilities of CEUS in the diagnostics of benign (angiomyolipomas, cysts, oncocytomas, pseudotumors) and malignant masses (renal cell carcinomas), and focuses on possible future treatment.
Literatur
1.
2.
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113:78–83.PubMedCrossRef
3.
Nepple KG, Yang L, Grubb III RL, Strope SA. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012;187:32–8.PubMedCrossRef
4.
Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. Radiographics. 2008;28:1325–38.PubMedCrossRef
5.
Millet I, Doyon FC, Hoa D, Thuret R, Merigeaud S, Serre I, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol. 2011;197:887–96.PubMedCrossRef
6.
Kummerlin I, ten KF, Smedts F, Horn T, Algaba F, Trias I, et al. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol. 2008;53:1219–25.PubMedCrossRef
7.
Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60:578–84.PubMedCrossRef
8.
Menogue SR, O'Brien BA, Brown AL, Cohen RJ. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int 2012.
9.
Sofikerim M, Tatlisen A, Canoz O, Tokat F, Demirtas A, Mavili E. What is the role of percutaneous needle core biopsy in diagnosis of renal masses? Urology. 2010;76:614–8.PubMedCrossRef
10.
Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy–a renaissance? J Urol. 2008;179:20–7.PubMedCrossRef
11.
Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62:491–504.PubMedCrossRef
12.
• Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20. This article provides a good overview of the figures concerning the distribution of benign and malignant renal masses and the involved treatments. PubMedCrossRef
13.
• Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006;175:2027–31. This article reports the amount of unnecessary surgery peformed in exist SRMs of benign origin after surgery in a large study cohort. PubMedCrossRef
14.
Weisbord SD, Palevsky PM. Strategies for the prevention of contrast-induced acute kidney injury. Curr Opin Nephrol Hypertens. 2010;19:539–49.PubMedCrossRef
15.
Azmin M, Harfield C, Ahmad Z, Edirisinghe M, Stride E. How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. Curr Pharm Des. 2012;18:2118–34.PubMedCrossRef
16.
Liu Y, Miyoshi H, Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Contr Release. 2006;114:89–99.CrossRef
17.
Wilson SR, Burns PN. Microbubble-enhanced US in body imaging: what role? Radiology. 2010;257:24–39.PubMedCrossRef
18.
Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol. 2001;37:1135–40.PubMedCrossRef
19.
• Blomley M, Claudon M, Cosgrove D. WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns. Ultrasound Med Biol. 2007;33:180–6. This article describes the safety of CEUS.PubMedCrossRef
20.
• Piscaglia F, Nolsoe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann NM, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33:33–59. This article describes the current guidelines and recommendations for the use of CEUS.PubMedCrossRef
21.
Murphy AM, Buck AM, Benson MC, McKiernan JM. Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology. 2009;73:1293–7.PubMedCrossRef
22.
Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181:2033–6.PubMedCrossRef
23.
Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF, et al. Clinical predictors of renal mass pathological features. BJU Int. 2011;107:735–40.PubMedCrossRef
24.
Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol. 2003;58:626–9.PubMedCrossRef
25.
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798–805.PubMedCrossRef
26.
Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R. 2009 update on the classification of renal epithelial tumors in adults. Int J Urol. 2009;16:432–43.PubMedCrossRef
27.
Kawaguchi S, Fernandes KA, Finelli A, Robinette M, Fleshner N, Jewett MA. Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance. J Urol. 2011;186:1218–22.PubMedCrossRef
28.
Lhermitte B, de Leval L. Interpretation of needle biopsies of the kidney for investigation of renal masses. Virchows Arch. 2012;461:13–26.PubMedCrossRef
29.
Fan L, Lianfang D, Jinfang X, Yijin S, Ying W. Diagnostic efficacy of contrast-enhanced ultrasonography in solid renal parenchymal lesions with maximum diameters of 5 cm. J Ultrasound Med. 2008;27:875–85.PubMed
30.
Haendl T, Strobel D, Legal W, Frieser M, Hahn EG, Bernatik T. Renal cell cancer does not show a typical perfusion pattern in contrast-enhanced ultrasound. Ultraschall Med. 2009;30:58–63.PubMedCrossRef
31.
Tamai H, Takiguchi Y, Oka M, Shingaki N, Enomoto S, Shiraki T, et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med. 2005;24:1635–40.PubMed
32.
Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008;180:836–43.PubMedCrossRef
33.
Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Lu MD. Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med. 2010;29:709–17.PubMed
34.
Lu Q, Wang W, Huang B, Li C, Li C. Minimal Fat Renal Angiomyolipoma: the initial study with contrast-enhanced ultrasonography. Ultrasound Med Biol 2012;38:1896–901.
35.
Bosniak MA. The Bosniak renal cyst classification: 25 years later. Radiology. 2012;262:781–5.PubMedCrossRef
36.
Smith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN, et al. Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology. 2012;262:152–60.PubMedCrossRef
37.
Weibl P, Klatte T, Kollarik B, Waldert M, Schuller G, Geryk B, et al. Interpersonal variability and present diagnostic dilemmas in Bosniak classification system. Scand J Urol Nephrol. 2011;45:239–44.PubMedCrossRef
38.
Aoki S, Hattori R, Yamamoto T, Funahashi Y, Matsukawa Y, Gotoh M, et al. Contrast-enhanced ultrasound using a time-intensity curve for the diagnosis of renal cell carcinoma. BJU Int. 2011;108:349–54.PubMedCrossRef
39.
Park BK, Kim B, Kim SH, Ko K, Lee HM, Choi HY. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol. 2007;61:310–4.PubMedCrossRef
40.
Clevert DA, Minaifar N, Weckbach S, Jung EM, Stock K, Reiser M, et al. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system. Clin Hemorheol Microcirc. 2008;39:171–8.PubMed
41.
42.
Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Lamberto S, Scribano E. Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol. 2001;11:2496–9.PubMedCrossRef
43.
Jinzaki M, Ohkuma K, Tanimoto A, Mukai M, Hiramatsu K, Murai M, et al. Small solid renal lesions: usefulness of power Doppler US. Radiology. 1998;209:543–50.PubMed
44.
Mazziotti S, Zimbaro F, Pandolfo A, Racchiusa S, Settineri N, Ascenti G. Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging. 2010;35:241–5.PubMedCrossRef
45.
Zhang C, Li X, Hao H, Yu W, He Z, Zhou L. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 2012.
46.
Jiang J, Chen Y, Zhou Y, Zhang H. Clear cell renal cell carcinoma: contrast-enhanced ultrasound features relation to tumor size. Eur J Radiol. 2010;73:162–7.PubMedCrossRef
47.
Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Liang JY, et al. Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging. 2010;35:750–6.PubMedCrossRef
48.
Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, et al. Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. AJR Am J Roentgenol. 2011;197:897–906.PubMedCrossRef
49.
Ignee A, Straub B, Brix D, Schuessler G, Ott M, Dietrich CF. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc. 2010;46:275–90.PubMed
50.
Mouraviev V, Joniau S, Van PH, Polascik TJ. Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol. 2007;51:328–36.PubMedCrossRef
51.
Zhao X, Wang W, Zhang S, Liu J, Zhang F, Ji C, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging. 2012;37:885–91.PubMedCrossRef
52.
Johnson DB, Duchene DA, Taylor GD, Pearle MS, Cadeddu JA. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion. J Endourol. 2005;19:248–52.PubMedCrossRef
53.
Slabaugh TK, Machaidze Z, Hennigar R, Ogan K. Monitoring radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: a porcine model. J Endourol. 2005;19:579–83.PubMedCrossRef
54.
Hoeffel C, Pousset M, Timsit MO, Elie C, Mejean A, Merran S, et al. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol. 2010;20:1812–21.PubMedCrossRef
55.
Meloni MF, Bertolotto M, Alberzoni C, Lazzaroni S, Filice C, Livraghi T, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol. 2008;191:1233–8.PubMedCrossRef
56.
Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189:429–36.PubMedCrossRef
57.
Wink MH, Laguna MP, Lagerveld BW, de la Rosette JJ, Wijkstra H. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU Int. 2007;99:1371–5.PubMedCrossRef
58.
Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol. 2004;14 Suppl 8:4–10.
59.
Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, Wisner ER, et al. Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging. 2008;3:9–18.PubMedCrossRef
60.
Barwari K, Wijkstra H, van Delden OM, de la Rosette J, Laguna P. Contrast-enhanced ultrasound for the evaluation of the cryolesion after laparoscopic renal cryoablation: an initial report. J Endourol 2012. doi:10.​1089/​end.​2012.​0400.
61.
Yin T, Wang P, Zheng R, Zheng B, Cheng D, Zhang X, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine. 2012;7:895–904.PubMed
62.
Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol. 2009;193:55–60.PubMedCrossRef
Metadaten
Titel
Evaluation of Renal Masses with Contrast-Enhanced Ultrasound
verfasst von
S. Houtzager
H. Wijkstra
J. J. M. C. H. de la Rosette
M. P. Laguna
Publikationsdatum
01.04.2013
Verlag
Current Science Inc.
Erschienen in
Current Urology Reports / Ausgabe 2/2013
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-013-0309-x

Weitere Artikel der Ausgabe 2/2013

Current Urology Reports 2/2013 Zur Ausgabe

Urothelial Cancer (A Sagalowsky, Section Editor)

Current Role of PET, CT, MR for Invasive Bladder Cancer

Bladder and Urothelial Cancer (A Sagalowsky, Section Editor)

Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer

Urothelial Cancer (A Sagalowsky, Section Editor)

Experience with Newer Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer

Minimally Invasive Surgery (V Bird, Section Editor)

Practice Patterns in the Management of Urinary Lithiasis

Bladder and Urothelial Cancer (A Sagalowsky, Section Editor)

Adjuvant Methods to Improve Results of Local Bladder Irrigations by Chemotherapy for NMIBC

Bladder and Urothelial Cancer (A Sagalowsky, Section Editor)

Improvements in Safety and Recovery Following Cystectomy: Reassessing the Role of Pre-Operative Bowel Preparation and Interventions to Speed Return of Post-Operative Bowel Function

Neu im Fachgebiet Urologie

Männern mit Zystitis Schmalband-Antibiotika verordnen

03.05.2024 Zystitis Nachrichten

Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

D-Mannose ohne Nutzen in der Prävention von HWI-Rezidiven

02.05.2024 Harnwegsinfektionen in der Urologie Nachrichten

D-Mannose, eine Hoffnungsträgerin in der Rezidivprophylaxe von Harnwegsinfektionen, hat in einer Studie nicht mehr bewirken können als ein Placebo. Die Empfehlung zur Einnahme entfalle damit, so die Autoren.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise